Event The Use of Medicines in the U.S. 2023 May 18, 2023 Video Global Trends in R&D 2023 Activity, Productivity, and Enablers Institute Report The Global Use of Medicines 2023 Outlook to 2027 Fact Sheet COVID-19 Continues to Impact Global Spending on Medicines Based on research in ...
In 2023, the World Health Organization (WHO) Model Lists of Essential Medicines, which regularly selects highly effective bio-products with prohibitively high prices, included two more biological agents targeting cancer and multiple sclerosis, partly due to the presence of their biosimilars that offer...
Design and Architecture of MES Solutions:A generic MES, modified for Pharma, would not succeed in Pharma. The eMES must be designed for Pharmaceutical operations, where the regulatory compliance requires flexibility in system to allow special process steps, for which there is no global best practic...
The global over the counter drugs market size was valued USD 46.65 billion in 2022 and is projected to grow USD 49.68 billion in 2023 to USD 73.78 billion by 2030, exhibiting a CAGR of 5.8% during forecast (2023-2030). North America accounted for a market value of USD 18.46 billion in ...
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China Tengfei Ji Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China Meiling...
Cell-based therapeutics are an emerging modality with the potential to treat many currently intractable diseases through uniquely powerful modes of action. Despite notable recent clinical and commercial successes, cell-based therapies continue to face numerous challenges that limit their widespread translation...
2023. Because there’s no one-size-fits-all treatment, our rankings group different types of products, so you can find options whether you want a combination medicine to manage multiple symptoms or are looking for relief from only one. There are also separate lists for children’s medicines ...
We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...
Positive use cases exist with more stakeholders investing in integrating RWD sources into their R&D decision-making activities. While many of the global RWD types resemble data from high-income countries (HIC's) that inform R&D in the developed world, much of it is not and the conditions of ...
The landscape for lipid-nanoparticle-based genomic medicines. Nat. Rev. Drug. Discov. 22, 349–350 (2023). Article CAS PubMed Google Scholar CONGRESS.GOV. S.5002 - FDA Modernization Act 2.0. https://congress.gov/bill117th-congress/senate-bill/5002 (2022). Ingber, D. E. Human organs-...